NCT07102147 Telehealth Collaborative Care Model (CoCM) in Lung Cancer
| NCT ID | NCT07102147 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Condition | Lung Cancer (Diagnosis) |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-08-18 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-08-18 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this trial is to compare the impact of two outreach strategies (high touch vs. standard outreach) on a collaborative care program delivered via telehealth to patients with lung cancer.
Eligibility Criteria
Inclusion Criteria: * Are aged 18 years or older. * Are currently being seen by Penn Medicine Thoracic Oncology for lung cancer treatment or survivorship care. * Are referred to collaborative care by a Penn Medicine Thoracic Oncology clinician for treatment of depression, anxiety, or other psycho-therapy services. Exclusion Criteria: * Are already receiving psycho-therapy treatment services outside of Penn Medicine's collaborative care program, Penn Integrated Care (PIC). * Have a significant and/or untreated medical and/or psychiatric co-morbidity (e.g., other cancers, schizophrenia, acute suicidal and/or homicidal ideation) that make them ineligible for the Penn CoCM program.
Contact & Investigator
Alexandria Muench, PsyD
PRINCIPAL INVESTIGATOR
University of Pennsylvania
Frequently Asked Questions
Who can join the NCT07102147 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer (Diagnosis). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07102147 currently recruiting?
Yes, NCT07102147 is actively recruiting participants. Contact the research team at jennifer.steltz@pennmedicine.upenn.edu for enrollment information.
Where is the NCT07102147 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT07102147 clinical trial?
NCT07102147 is sponsored by Abramson Cancer Center at Penn Medicine. The principal investigator is Alexandria Muench, PsyD at University of Pennsylvania. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.